Entity

Time filter

Source Type


Novikova E.G.,Pa Herzen Moscow Research Oncology Institute | Shevchuk A.S.,Pa Herzen Moscow Research Oncology Institute
Voprosy Onkologii | Year: 2014

Contemporary possibilities of conserving therapy for borderline ovarian tumors are considered. There are analyzed world data on recurrence rates and fertility rates after different variants of conservative surgery. An experience of performing ultra-conserving surgery in patients with bilateral borderline ovarian tumors at the onco-gynecological clinic of the P.A. Herzen Moscow Research Oncology Institute is presented. Source


Novikova O.V.,Pa Herzen Moscow Research Oncology Institute | Andreeva Yu.Yu.,Moscow Medical Academy | Novikova E.G.,Pa Herzen Moscow Research Oncology Institute | Vostrov A.N.,Pa Herzen Moscow Research Oncology Institute | And 5 more authors.
Voprosy Onkologii | Year: 2014

There are presented the results of conservative treatment of 121 patients with endometrial atypical hyperplasia (EAH) and the initial endometrial cancer (EC) with preservation of fertility. In EAH (n = 56) during 6 months there was used the intrauterine spiral Mirena. The efficiency was 91%, the recurrence rate - 16%, pregnancies occurred in 16 % of patients. In EC (n = 65) hormone therapy was conducted during 6 months using the intrauterine spiral Mirena and zoladex. The efficiency was 79%, recurrence rate - 22%, pregnancies occurred in 24 % of patients. Basing on own data and the results of other studies the benefits and risks of independent hormone therapy for EAH and EC are discussed in women of reproductive age. Source

Discover hidden collaborations